European Pharmacovigilance Update Still Causing Concern
This article was originally published in The Pink Sheet Daily
Executive Summary
The European pharma industry understands the need to tighten EU pharmacovigilance rules, but increased powers for a new advisory and assessment body could signal trouble ahead.